This is the authors' abstract. We don't add key points for this paper.
Ribosome-targeting antibiotics represent an important class of antimicrobial drugs. Chloramphenicol (Cm) is a well-studied peptidyl transfer center (PTC) binder, and growing evidence suggests it inhibits translation in a nascent peptide sequence-dependent manner. How such inhibition on the molecular scale translates to action on the cellular level remains unclear. Here, we employ cryo-electron tomography to visualize the impact of Cm inside the bacterium Mycoplasma pneumoniae . By resolving cellular Cm-bound ribosomes to 3.0 Å, we provide atomic detail on Cm’s coordination and interaction with natural nascent peptides and tRNAs in the PTC. We find that Cm leads to accumulation of translation elongation states that indicate ongoing futile accommodation cycles, and to extensive ribosome collisions. We thus suggest that beyond its inhibition of protein synthesis, the action of Cm may involve activation of cellular stress responses. This work exemplifies how in-cell structural biology advances understanding of mechanisms of action for extensively-studied antibiotics.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Xue et al. (2023) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: